Literature DB >> 15832294

Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice.

Tatsuhiko Miyazaki1, Masao Ono, Wei-Min Qu, Ming-Cai Zhang, Shiro Mori, Shuichi Nakatsuru, Yusuke Nakamura, Tatsuya Sawasaki, Yaeta Endo, Masato Nose.   

Abstract

Potentially, autoimmune diseases develop from a combination of multiple genes with allelic polymorphisms. An MRL/Mp-Fas(lpr) (/) (lpr) (MRL/lpr) strain of mice develops autoimmune diseases, including lupus nephritis, but another lpr strain, C3H/HeJ-Fas(lpr) (/) (lpr) (C3H/lpr) does not. This indicates that MRL polymorphic genes are involved in the development of the diseases. By quantitative trait loci (QTL) analysis using 527 of the (MRL/lpr x C3H/lpr)F(2) mice, we identified a novel locus for susceptibility to lupus nephritis at map position D5Mit115 on chromosome 5, the same alias of the osteopontin (Opn) gene (LOD score =4.0), susceptible in the MRL allele. In functional analyses of the MRL and C3H Opn alleles using synthetic osteopontin (OPN) made with a new method "cell-free system" with wheat germ ribosomes, the MRL-OPN induced higher expression and production of immunoglobulins as well as cytokines including TNF-alpha, IL-1beta and IFN-gamma in splenocytes and/or macrophages than that of the C3H allele. These findings suggest that allelic polymorphism of OPN causes the functional differences in antibody production and macrophage activation between MRL and C3H strains, possibly involved in the development of lupus nephritis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15832294     DOI: 10.1002/eji.200425672

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  27 in total

Review 1.  Challenge of liver disease in systemic lupus erythematosus: Clues for diagnosis and hints for pathogenesis.

Authors:  Fernando Bessone; Natalia Poles; Marcelo G Roma
Journal:  World J Hepatol       Date:  2014-06-27

2.  Quantitative trait locus analysis of ovarian cysts derived from rete ovarii in MRL/MpJ mice.

Authors:  Shin-hyo Lee; Osamu Ichii; Saori Otsuka; Yoshiharu Hashimoto; Yasuhiro Kon
Journal:  Mamm Genome       Date:  2010-02-25       Impact factor: 2.957

3.  Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells.

Authors:  Mari L Shinohara; Linrong Lu; Jing Bu; Miriam B F Werneck; Koichi S Kobayashi; Laurie H Glimcher; Harvey Cantor
Journal:  Nat Immunol       Date:  2006-04-09       Impact factor: 25.606

Review 4.  Genetics of systemic lupus erythematosus and Sjögren's syndrome.

Authors:  R Hal Scofield
Journal:  Curr Opin Rheumatol       Date:  2009-09       Impact factor: 5.006

Review 5.  Genetic associations in type I interferon related pathways with autoimmunity.

Authors:  Angélica M Delgado-Vega; Marta E Alarcón-Riquelme; Sergey V Kozyrev
Journal:  Arthritis Res Ther       Date:  2010-04-14       Impact factor: 5.156

Review 6.  Regulation of T-helper-cell lineage development by osteopontin: the inside story.

Authors:  Harvey Cantor; Mari L Shinohara
Journal:  Nat Rev Immunol       Date:  2009-02       Impact factor: 53.106

7.  Retained features of embryonic metabolism in the adult MRL mouse.

Authors:  Robert K Naviaux; Thuy P Le; Khamilia Bedelbaeva; John Leferovich; Dmitri Gourevitch; Pawel Sachadyn; Xiang-Ming Zhang; Lise Clark; Ellen Heber-Katz
Journal:  Mol Genet Metab       Date:  2009-01-07       Impact factor: 4.797

8.  A bacterial artificial chromosome transgene with polymorphic Cd72 inhibits the development of glomerulonephritis and vasculitis in MRL-Faslpr lupus mice.

Authors:  Hisashi Oishi; Takahito Tsubaki; Tatsuhiko Miyazaki; Masao Ono; Masato Nose; Satoru Takahashi
Journal:  J Immunol       Date:  2013-01-30       Impact factor: 5.422

9.  Genomics of vasculitis: lessons from mouse models.

Authors:  Masato Nose; Hiroaki Komori; Tatsuhiko Miyazaki; Shiro Mori
Journal:  Ann Vasc Dis       Date:  2013-02-15

10.  Serum osteopontin, but not OPN gene polymorphism, is associated with LVH in essential hypertensive patients.

Authors:  Xuwei Hou; Zhaohui Hu; Xiaohua Huang; Yan Chen; Xiuying He; Haiying Xu; Ningfu Wang
Journal:  J Mol Med (Berl)       Date:  2013-12-27       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.